Interaction Guide · Research summary

Can I take S-Adenosylmethionine with Protriptyline?

Review S-Adenosylmethionine with Protriptyline: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

A specific serotonin-syndrome or high-blood-pressure interaction between SAMe and protriptyline is not established. Discuss a mood supplement with the prescriber before adding it.

What this answer covers

Oral S-adenosylmethionine supplement; not ordinary dietary nutrients.

Supplement or preparation
S-Adenosylmethionine
Medication ingredient
protriptyline

Separate general advice from exact evidence

NCCIH raises possible interactions between SAMe and serotonin-increasing products. Protriptyline’s exact label does not specifically name SAMe or serotonin syndrome.

Other treatment trials do not settle this pair

A SAMe add-on study in people taking serotonin-reuptake inhibitors found benefit. It does not establish a protriptyline group or quantify this combination’s risks.

High blood pressure is not demonstrated here

Protriptyline has cardiovascular precautions, but the inspected sources do not show that adding SAMe causes hypertension. Do not use a presumed interaction to alter the prescription.

Include mood history and other products

SAMe guidance flags bipolar disorder concerns. Bring your mood history and full medication list to the prescriber before adding it.

Evidence and practical considerations

Side effects & toxicity

Exact serotonin syndrome and hypertension claims remain insufficiently established.

Exact scope
Oral S-adenosylmethionine supplement; not ordinary dietary nutrients. with Exact oral protriptyline hydrochloride film-coated tablets. RxNorm IN8886 / PIN203199 hydrochloride tablets. Label describes activating properties and lack of sedative/tranquilizing properties; do not assume other tricyclic sedation applies.
Medication form and route
oral
Timing or duration
Source-specific single-dose, repeated-dose and observational exposures distinguished.

What remains uncertain

  • General serotonergic warnings and other-antidepressant augmentation trials do not establish protriptyline-specific outcomes.

Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral protriptyline.

Label describes activating properties and lack of sedative/tranquilizing properties. Cardiovascular, anticholinergic and MAOI precautions; no explicit serotonin syndrome or St John’s wort warning.

How this applies: RxNorm IN8886 / PIN203199 hydrochloride tablets. Label describes activating properties and lack of sedative/tranquilizing properties; do not assume other tricyclic sedation applies.

No universal supplement interval, event rate or preparation equivalence established.

Source 2: official supplement guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: People considering SAMe.

Possible interaction with serotonin-increasing medicines and supplements; bipolar disorder and limited long-term safety warrant review.

How this applies: Supplement-only reason for review, not a specific protriptyline contraindication.

General serotonergic and bipolar precautions; no exact protriptyline serotonin syndrome or hypertension finding.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 73 serotonin reuptake inhibitor nonresponders with major depression.

Response and remission favored SAMe; discontinuation due to adverse events was not significantly different.

How this applies: Indirect trial context, not protriptyline efficacy or toxicity proof.

Mixed serotonin-reuptake-inhibitor augmentation study; no protriptyline group established.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact available claims adjudicated using original captures and explicit identity and comparator limits.
Research summary published

Article revision: 17172c91a4c4a060

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.